Therapy-induced tumour secretomes promote resistance and tumour progressionAnna C. Obenauf, Joan Massagué, Yilong Zou et al.|Nature|2015Cited by 502
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaLisa Haas, Anna C. Obenauf, Camille L. Gérard et al.|Nature Cancer|2021Cited by 196
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Anna C. Obenauf, Guillem Estivill et al.|Nature|2024Cited by 122
A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinomaSaiful Effendi Syafruddin, Sakari Vanharanta|Nature Communications|2019Cited by 102
The SWI/SNF complex member SMARCB1 supports lineage fidelity in kidney cancerLudovic Wesolowski, Sakari Vanharanta|iScience|2023Cited by 5